A detailed history of Archer Investment Corp transactions in Novartis Ag stock. As of the latest transaction made, Archer Investment Corp holds 171 shares of NVS stock, worth $16,600. This represents 0.01% of its overall portfolio holdings.

Number of Shares
171
Previous 86 98.84%
Holding current value
$16,600
Previous $9.16 Million 114.81%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$106.13 - $120.89 $9,021 - $10,275
85 Added 98.84%
171 $19.7 Million
Q2 2024

Aug 02, 2024

SELL
$92.57 - $107.37 $277 - $322
-3 Reduced 3.37%
86 $9.16 Million
Q2 2023

Aug 08, 2023

BUY
$92.52 - $104.91 $6,013 - $6,819
65 Added 270.83%
89 $8.98 Million
Q3 2021

Oct 29, 2021

BUY
$81.78 - $95.14 $1,962 - $2,283
24 New
24 $1.96 Million
Q2 2021

Aug 05, 2021

SELL
$85.24 - $94.15 $2,045 - $2,259
-24 Closed
0 $0
Q3 2019

Apr 01, 2020

BUY
$85.54 - $94.26 $2,052 - $2,262
24 New
24 $2,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Archer Investment Corp Portfolio

Follow Archer Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.